- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/108 - Escherichia; Klebsiella
Patent holdings for IPC class A61K 39/108
Total number of patents in this class: 601
10-year publication summary
52
|
58
|
50
|
39
|
44
|
47
|
54
|
48
|
35
|
14
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Glaxosmithkline Biologicals S.A. | 1701 |
48 |
Janssen Pharmaceuticals, Inc. | 399 |
38 |
Qu Biologics Inc. | 33 |
17 |
Zoetis Services LLC | 1537 |
15 |
Cornell University | 3036 |
14 |
University of Maryland, Baltimore | 999 |
13 |
The United States of America as represented by the Secretary of the Navy | 2734 |
12 |
Sequoia Vaccines, Inc. | 14 |
12 |
Pfizer Inc. | 3322 |
11 |
Scandinavian Biopharma Holding AB | 17 |
9 |
Northwestern University | 3112 |
8 |
Vaxxinova US, Inc. | 54 |
8 |
The Board of Trustees of the University of Illinois | 2623 |
7 |
Board of Trustees of the University of Arkansas | 771 |
6 |
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 357 |
6 |
The Johns Hopkins University | 5377 |
5 |
Idemitsu Kosan Co., Ltd. | 3995 |
5 |
The Administrators of the Tulane Educational Fund | 368 |
5 |
South Dakota State University | 74 |
5 |
The Texas a & M University System | 1519 |
5 |
Other owners | 352 |